Risk Management Executive, James Hice, Named Risk Manager and General Counsel at McCusker & Company

Legal and risk management expertise and industry knowledge will be invaluable for our company

2014-03-30

FORT WORTH, TX, March 30, 2014 (Press-News.org) Risk Management executive, and highly-regarded industry insider, James Hice, was today named Risk Manager and General Counsel at McCusker & Company, a leading international provider of warranty protection solutions for the commercial and consumer electronics industry.

"I am pleased to name James Hice our new Risk Manager and General Counsel," said McCusker & Company Chief Executive Officer Will L. McCusker. "His connections, insight, expertise and industry knowledge will be invaluable for our company."

Hice was the Vice President of Operations and Procurement at 5 Star Contracting. In that role, he was directly responsible for establishing processes and providing leadership to promote the growth of the firm's operations. He also was in charge of prime contract development, contract negotiations, human resource oversight, budget verification and validation, pre-construction management, estimating, operations management, legal risk management and business development.

He also has acted as the Vice President of Navy Construction Operations at Actus Land Lease, Senior Construction Manager at Pavarini SE General Contractors and Regional Vice President/Regional Risk Manager at WG Yates Construction.

Hice received a Purple Heart and Silver Star as a member of the United States Marine Corps and achieved the rank of Colonel aviator. Hice holds a Juris Doctorate law degree and has practiced law. Hice resides in Euless Texas and enjoys golf, travel and support of the military in his spare time.

"His experience will help provide McCusker & Company with the strategic leadership needed to take our company to its next level of growth and market development," McCusker said. "He has already started to outline a legal and risk management strategy for long-term sustainable expansion of our core business along with some innovations into new opportunities for growth."

McCusker & Company is a leading provider of extended warranty services for a number of consumer technology products including cell phones, smart phones, LED lighting and other high-technology products. For more information about their products and services, please check out their website at www.mccuskerco.com.

McCusker & Company is an extended warranty-consulting firm founded by industry experts and is headquartered in the Dallas-Fort Worth Metroplex. Its international division, known as McCusker & Company of the Caribbean, has an office in San Juan, Puerto Rico.

It specializes in the extended warranty service contract industry providing consulting, extended warranty programs, service programs, management and support for your warranty call center and on-site service needs. McCusker & Company also functions as litigation consulting experts on complex litigation projects, technology sales, and arbitration and industry disputes.

For more information call 800-734-0819.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Envision Built Offers Custom Built Transformations of Screened Porches and Patios into Spacious Three Season Sunrooms to Extend Living Spaces in Cary, Durham and the Greater Raleigh NC Area

2014-03-30

Envision Built Home Remodeling is a custom home renovation specialist - transform your screened porch or patio into a three seasons sunroom, extending the living space of your home. Envision Built is an award-winning remodeling designer and builder. "A fairly easy way to extend the living space in your home is convert your screened porch or patio into a beautiful sunroom," said Bill Ahle, Owner of Envision Built. "Every major renovation begins with a five hour design session working with our interior designer to help you develop a plan, select color schemes and to map ...

SchureMed to Unveil Schure Loc XPS Medical Device at AORN in Chicago

2014-03-30

SchureMed announced today plans to present their newest and most innovative surgical positioning device at the AORN Show at McCormick Place in Chicago IL. The Schure Loc XPS Extremity Positioning System advances surgical patient positioning by combining both absolute rigid fixation of the patient's limb with unlimited range of motion both pre- and intra-operatively during shoulder arthroscopy, rotator cuff and total shoulder replacement procedures. Unlike other devices that use bulky hydraulic systems and supplementary power units, the Schure Loc XPS employs an ingenious ...

Texas Based Modern Intellects Artist Gift Releases The Trip EP

2014-03-29

The release of Gift's EP "The Trip" has been eagerly awaited by fans since mid-2013, the uniquely creative video countdown gave fans but a glimpse inside the mind of the independent rapper and the creative process of the project, leaving listeners and viewers wanting more. Gift first began writing at 16 years old after a serious hamstring injury that ended his future in track and field, but ended up being what would pave the way for his future. Fans have the choice of downloading the EP for free or making a donation by visiting www.giftrapsmusic.com or the artist's SoundCloud ...

Relaxed blood pressure guidelines cut millions from needing medication

2014-03-29

DURHAM, N.C. – New guidelines that ease the recommended blood pressure could result in 5.8 million U.S. adults no longer needing hypertension medication, according to an analysis by Duke Medicine researchers. The findings are the first peer-reviewed analysis to quantify the impact of guidelines announced in February by the Eighth Joint National Committee. In a divisive move, the committee relaxed the blood pressure goal in adults 60 years and older to 150/90, instead of the previous goal of 140/90. Blood pressure goals were also eased for adults with diabetes and kidney ...

Study estimates proportion of adults affected by new blood pressure guideline

2014-03-29

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. Ann Marie Navar-Boggan, M.D., Ph.D., of Duke University Medical Center, Durham, N.C., and colleagues quantified the proportion of adults potentially ...

US, European cholesterol guidelines differ in statin use recommendations

2014-03-29

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary prevention is to identify individuals at high enough risk to justify more intensive lifestyle ...

Analysis supports use of risk equations to guide statin therapy

2014-03-29

In an analysis of almost 11,000 patients, an assessment of equations that help guide whether a patient should begin taking a statin (cholesterol lowering medication) found that observed and predicted 5-year atherosclerotic cardiovascular disease risks were similar, suggesting that these equations are helpful for clinical decision making, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published ...

Celiac disease linked to increased risk of coronary artery disease

2014-03-29

People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. The study is the first to look at the association between celiac disease and coronary artery disease and adds to the evolving understanding of how systemic inflammation and autoimmune processes might influence cardiovascular disease development. Data also showed a slightly higher risk of stroke among people with celiac disease compared ...

Are statins good for your love life?

2014-03-29

Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Previous research has suggested a negative association between statin therapy and testosterone levels, leading to ...

Study finds astronauts' hearts become more spherical in space

2014-03-29

New findings from a study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. With implications for an eventual manned mission to Mars, the findings represent an important step toward understanding how a spaceflight of 18 months or more could affect astronauts' heart health. "The heart doesn't work as hard in space, which can cause a loss of muscle mass," ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC